Longevity science has attracted more venture capital, more celebrity endorsement, and more credentialed scientific attention in the past decade than in all previous decades combined. The results have been, with a small number of genuine exceptions, a sustained disappointment relative to the hype. The core problem is biological complexity. Aging is not a single mechanism with a … [Read more...] about Why Longevity Science Keeps Failing to Deliver
health
The Obesity Drug Market Is Bigger Than Anyone Planned For
The GLP-1 drug category — Ozempic, Wegovy, Mounjaro, and the compounds behind them — has produced one of the fastest market expansions in pharmaceutical history. The forecasts keep being revised upward because the forecasts keep underestimating demand. Part of what makes this unusual is that the demand is coming from multiple directions simultaneously. There is the core … [Read more...] about The Obesity Drug Market Is Bigger Than Anyone Planned For